共 16 条
[1]
New highly lipophilic camptothecin BNP1350 is an effective drug in experimental human cancer. Van Hattum AH,Pinedo HM,Schluper HM,et al. International Journal of Cancer . 2000
[2]
In vitro and in vivo characterization of XR11576, a novel, orally active, dual inhibitor of topoisomerase Ⅰ and Ⅱ. Mistry P,Stewart AJ,Dangerfield W,et al. Anti Cancer Drugs . 2002
[3]
Differential cytotoxicity of clinically important camptothecin derivatives in P-glycoprotein-overexpressing cell lines. Hoki Y,Fujimori A,Pommier Y. Cancer Chemother . 1997
[4]
Markers of drug resistance in relapsing colon cancer. Lazaris AC,Kavantzas NG,Zorzos HS,et al. Journal of Cancer Research and Clinical Oncology . 2002
[5]
Incidence of muta-tion and deletionin topoisomeraseⅡalpha mRNA of etoposide and mAMSA-resistant cell lines. Matsumoto Y,Takano H,Kunishio K,et al. Japanese Journal of Cancer Research . 2001
[6]
Down-regulation of DNA topoisomerase IIalpha in human colorectal carcinoma cells resistant to a protoberberine alkaloid, berberrubine. Kang MR,Chung IK. Molecular Pharmacology . 2002
[7]
Transcription factor c-Jun activation repres- ses mdr-1 gene expression. MIAO ZH,DING J. Cancer Research . 2003
[8]
Expression of drug resistance genes in VP-16 and mAMSA-selected human carcinoma cells. Matsurmoto Y,Takano H,Kunishio K,et al. Japanese Journal of Cancer Research . 2001
[9]
Nuclear localization of proteasomes participates in stress-inducible resistance of solid tumor cells to topoisomerase Ⅱ-directed drugs. Ogiso Y,Tomida A,Tsuruo T. Cancer Research . 2002
[10]
Mechanisms of taxotere-related drug resistance in pancreatic carcinoma. Liu B,Staren ED,Iwamura T,et al. Journal of Surgical Research . 2001